Skip to Main Content

The Bulletin - Fall 2025

PDF

  • Court in Social Media Multidistrict Litigation Will Begin Bellwether Trials in June 2026

    Matthew Macken

    After nearly two years of litigation, the Court presiding over In re Social Media Adolescent Addiction/Personal Injury Products Liability Litigation, 22-md-03047 (N.D. Cal.)—a multidistrict litigation (“MDL”) involving lawsuits filed by hundreds of school districts and local governments around the...

  • The Revived Discussion about Eliminating Mandatory Quarterly Reporting for U.S. Public Companies

    Joshua Keszczyk, Geoffrey Jarvis

    THE REVIVED DISCUSSION ABOUT ELIMINATING MANDATORY QUARTERLY REPORTING FOR U.S. PUBLIC COMPANIES President Donald Trump recently called on the U.S. Securities and Exchange Commission (“SEC”) to eliminate the mandatory quarterly reporting requirements for public companies listed on U.S. exchanges...

  • KTMC Achieves $100 Million Settlement for Online Advertisers in Google AdWords Consumer Fraud Litigation

    Matthew Mustokoff, Margaret Mazzeo

    After 14 years of litigation, Kessler Topaz recently secured a landmark $100 million recovery on behalf of two classes of online advertisers in Rene Cabrera, et al. v. Google LLC, 11-cv-1263-EJD (N.D. Cal.). The settlement, approved by U.S. District Judge Edward J. Davila of the Northern District...

  • Chancellor Says "Game-On" to KTMC's Activision-Microsoft Merger Litigation

    Lauren Lummus

    On October 2, 2025, Chancellor McCormick of the Delaware Court of Chancery (the “Court”) issued a decision (the “Opinion”) largely denying Defendants’ second motions to dismiss in the long-running stockholder litigation (the “Action”) challenging the $70 billion merger (the “Merger”) of Microsoft...

  • Kessler Topaz Represents Health & Welfare Funds Seeking to Recover Overcharges from the Illegal Delay of Generic Competition to Two Blockbuster Drugs

    Barbara Schwartz

    Kessler Topaz recently filed two class action complaints on behalf of certain drug purchasers, including health plans, that overpaid for two blockbuster prescription drugs -- Entresto and Xifaxan.[1] These two cases seek to hold brand and generic drug companies accountable for abusing the...

  • 8th Circuit Rejects SEC Attempt to End Climate Disclosure Rules

    Karissa Sauder

    Since President Trump again took office in January 2025, the United States Securities and Exchange Commission (the “SEC”) has been revisiting a number of its positions on policies instituted during the Biden Administration. One such attempt to revise polices previously established pursuant to...

  • Rule 23(F) Petitions: A Vehicle for Challenging Plaintiffs' Proposed Class-Wide Damages Model

    Marianne Uy

    Introduction Class certification is a pivotal point in all class actions. For class actions brought in federal court, plaintiffs seeking to represent a class must establish that their claims meet all the prerequisites of Federal Rule of Civil Procedure (“Rule”) 23. Rule 23(a) requires that a...